BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25824466)

  • 1. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
    Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
    J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
    Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
    Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidovanadium(IV) and dioxidovanadium(V) complexes of tridentate salicylaldehyde semicarbazones: searching for prospective antitrypanosomal agents.
    Fernández M; Becco L; Correia I; Benítez J; Piro OE; Echeverria GA; Medeiros A; Comini M; Lavaggi ML; González M; Cerecetto H; Moreno V; Pessoa JC; Garat B; Gambino D
    J Inorg Biochem; 2013 Oct; 127():150-60. PubMed ID: 23528424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
    Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
    J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
    Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
    J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: a potential anti-protozoa and anti-tumor agent.
    Benítez J; Guggeri L; Tomaz I; Pessoa JC; Moreno V; Lorenzo J; Avilés FX; Garat B; Gambino D
    J Inorg Biochem; 2009 Oct; 103(10):1386-94. PubMed ID: 19695708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
    Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
    J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of vanadium mixed-ligand complexes as potential anti-protozoa agents.
    Benítez J; Guggeri L; Tomaz I; Arrambide G; Navarro M; Pessoa JC; Garat B; Gambino D
    J Inorg Biochem; 2009 Apr; 103(4):609-16. PubMed ID: 19091422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
    Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
    Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.
    Maurya MR; Khan AA; Azam A; Ranjan S; Mondal N; Kumar A; Avecilla F; Pessoa JC
    Dalton Trans; 2010 Feb; 39(5):1345-60. PubMed ID: 20104362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of
    Scalese G; Machado I; Salinas G; Pérez-Díaz L; Gambino D
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cellular uptake, cytotoxicity and cellular ultrastructural effects of heteroleptic oxidovanadium(IV) complexes of salicylaldimines and polypyridyl ligands.
    Scalese G; Correia I; Benítez J; Rostán S; Marques F; Mendes F; Matos AP; Costa Pessoa J; Gambino D
    J Inorg Biochem; 2017 Jan; 166():162-172. PubMed ID: 27865131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
    Scalese G; Mosquillo MF; Rostán S; Castiglioni J; Alho I; Pérez L; Correia I; Marques F; Costa Pessoa J; Gambino D
    J Inorg Biochem; 2017 Oct; 175():154-166. PubMed ID: 28755573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-target heteroleptic palladium bisphosphonate complexes.
    Cipriani M; Rostán S; León I; Li ZH; Gancheff JS; Kemmerling U; Olea Azar C; Etcheverry S; Docampo R; Gambino D; Otero L
    J Biol Inorg Chem; 2020 May; 25(3):509-519. PubMed ID: 32232584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonamide-metal complexes endowed with potent anti-Trypanosoma cruzi activity.
    Chohan ZH; Hernandes MZ; Sensato FR; Moreira DR; Pereira VR; Neves JK; de Oliveira AP; de Oliveira BC; Leite AC
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):230-6. PubMed ID: 23432595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
    Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
    Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) complexes of substituted salicylaldehyde dibenzyl semicarbazones: synthesis, cytotoxicity and interaction with quadruplex DNA.
    Munira Haidad Ali S; Yan YK; Lee PP; Khong KZ; Alam Sk M; Lim KH; Klejevskaja B; Vilar R
    Dalton Trans; 2014 Jan; 43(3):1449-59. PubMed ID: 24202733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and in vitro trypanocidal and leishmanicidal activities of novel semicarbazone derivatives.
    Alves MA; de Queiroz AC; Alexandre-Moreira MS; Varela J; Cerecetto H; González M; Doriguetto AC; Landre IM; Barreiro EJ; Lima LM
    Eur J Med Chem; 2015 Jul; 100():24-33. PubMed ID: 26069927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligational behavior of thiosemicarbazone, semicarbazone and thiocarbohydrazone ligands towards VO(IV), Ce(III), Th(IV) and UO2(VI) ions: synthesis, structural characterization and biological studies.
    Shebl M; Seleem HS; El-Shetary BA
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jan; 75(1):428-36. PubMed ID: 19963432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.
    Fernández M; Arce ER; Sarniguet C; Morais TS; Tomaz AI; Azar CO; Figueroa R; Diego Maya J; Medeiros A; Comini M; Helena Garcia M; Otero L; Gambino D
    J Inorg Biochem; 2015 Dec; 153():306-314. PubMed ID: 26275470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.